SYK Stock Recent News

LIFEPAK 35, a clinically advanced monitor/defibrillator, reduces caregiver burden and streamlines workflow.1 PORTAGE, Mich., USA, June 4, 2024 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced the launch of LIFEPAK 35 monitor/defibrillator, the latest product in the monitor/defibrillator space, offering advanced technology and built on an intuitive1, modern platform to help advance patient care.

KALAMAZOO, Mich.--(BUSINESS WIRE)--Stryker announced the signing of a definitive agreement to acquire all of the issued and outstanding shares of Artelon.

Stryker (SYK) announces plan to launch its Gamma4 Hip Fracture Nailing System in Europe. It completes initial surgeries successfully.

Stryker (SYK) issues urgent field safety notice for the Mako Total Knee systems, the application software of which generated software error codes. The company also shares risk mitigation steps.

AMSTERDAM, Netherlands--(BUSINESS WIRE)--The first surgeries utilizing Stryker's Gamma4 Hip Fracture Nailing System were completed in Europe.

Stryker's (SYK) first-quarter earnings reflect strong performance across its segments and geographies. Operating and gross margins increase, with earnings and revenues beating their respective estimates.

Start Time: 16:30 January 1, 0000 5:28 PM ET Stryker Corporation (NYSE:SYK ) Q1 2024 Earnings Conference Call April 30, 2024, 16:30 PM ET Company Participants Kevin Lobo - Chair and CEO Glenn Boehnlein - VP and CFO Jason Beach - VP, Finance and IR Conference Call Participants Robert Marcus - JPMorgan Lawrence Biegelsen - Wells Fargo Securities Ryan Zimmerman - BTIG Joanne Wuensch - Citibank Pito Chickering - Deutsche Bank Shagun Singh Chadha - RBC Capital Vijay Kumar - Evercore Travis Steed - Bank of America Matthew O'Brien - Piper Sandler Matt Miksic - Barclays Danielle Antalffy - UBS Matt Taylor - Jefferies Caitlin Cronin - Canaccord Sam Brodovsky - Truist Joshua Jennings - Cowen Andrew Ranieri - Morgan Stanley Operator Welcome to the First Quarter 2024 Stryker Earnings Call. My name is Christine, and I'm your operator for today's call.

Stryker Corp lifted its full-year profit forecast on Tuesday, owing to resilient demand for the company's medical devices and implants.

The headline numbers for Stryker (SYK) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Stryker (SYK) came out with quarterly earnings of $2.50 per share, beating the Zacks Consensus Estimate of $2.35 per share. This compares to earnings of $2.14 per share a year ago.